Portfolio - Sands Capital Ventures

Partners for long-term growth

When you partner with Sands Capital, you access the full scope of research, networks and insights across the Sands Capital platform. We use our Six Investment Criteria established almost 30 years ago to identify high-quality growth companies and fuel their businesses.

Team

0 +

Businesses

$ 0 B

Invested

Company

Status

The case studies provided herein are a selection of investments that we believe illustrate our investment approach and philosophy, as well as the range of businesses in which Sands Capital typically invests. They were selected on an objective basis. The case studies are being provided for discussion purposes only and the information included should not be relied upon to make any investment decision.

The actual realizations on unrealized investments will depend on, among other factors, future operating results of the investments, the value of the underlying assets, and market conditions at the time of disposition, distribution, or initial public offering.

Active Exited Life Sciences Technology

Latest Oldest Name A-Z Name Z-A

Active

Exited

Life Sciences

Technology

Status: NASDAQ: TXG

Category: Life Sciences

Partner Since: April 2022

Visit Website

Read case study

10X Genomics

1648827780

Show details

Status: NASDAQ: MASS

Category: Life Sciences

Partner Since: April 2019

Visit Website

Read case study

908 Devices

1554133440

Show details

Status: Exited

Category: Life Sciences

Partner Since: June 2017

Visit Website

Read case study

Acessa Health

1496277217

Show details

Status: NASDAQ: ACRV

Category: Life Sciences

Partner Since: November 2021

Visit Website

Read case study

Acrivon Therapeutics

1637077680

Show details

Status: NASDAQ: ABOS

Category: Life Sciences

Partner Since: November 2020

Visit Website

Read case study

Acumen Pharmaceuticals

1604245740

Show details

Status: Exited

Category: Life Sciences

Partner Since: February 2017

Visit Website

Read case study

Agilis Bio

1485964200

Show details

Status: Exited

Category: Technology

Partner Since: May 2014

Visit Website

Read case study

Anaplan

1398904414

Show details

Status: Active

Category: Life Sciences

Partner Since: June 2021

Visit Website

Read case study

Ancora Heart

1622562720

Show details

Status: Active

Category: Life Sciences

Partner Since: August 2021

Visit Website

Read case study

Ankyra

1627819920

Show details

Status: Exited

Category: Technology

Partner Since: July 2014

Visit Website

Read case study

AppDynamics

1404229920

Show details

Status: Acquired

Category: Life Sciences

Partner Since: December 2019

Visit Website

Read case study

ArcherDx

1575164400

Show details

Status: Exited

Category: Life Sciences

Partner Since: June 2017

Visit Website

Read case study

Avitide

1496282520

Show details

Status: Active

Category: Life Sciences

Partner Since: August 2023

Visit Website

Read case study

Beta Bionics

Show details

Status: Exited

Category: Technology

Partner Since: October 2015

Visit Website

Read case study

BigBasket

1443664920

Show details

Status: Active

Category: Life Sciences

Partner Since: March 2021

Visit Website

Read case study

BioSplice Therapeutics

1614560460

Show details

Status: Active

Category: Technology

Partner Since: January 2017

Visit Website

Read case study

BlackBuck

1483232460

Show details

Status: Active

Category: Technology

Partner Since: November 2021

Visit Website

Read case study

Bloop

1635782340

Show details

Status: Featured

Category: Technology

Partner Since: July 2019

Visit Website

Read case study

Boom Entertainment

1561982520

Show details

Status: Active

Category: Technology

Partner Since: March 2019

Visit Website

Read case study

Brightflag

1551402060

Show details

Status: Active

Category: Technology

Partner Since: September 2020

Visit Website

Read case study

Byju's

1598922060

Show details

Status: Active

Category: Life Sciences

Partner Since: March 2019

Visit Website

Read case study

Candel

1551402060

Show details

The case studies provided herein are a selection of investments that we believe illustrate our investment approach and philosophy, as well as the range of businesses in which Sands Capital typically invests. They were selected on an objective basis. The case studies are being provided for discussion purposes only and the information included should not be relied upon to make any investment decision.

The actual realizations on unrealized investments will depend on, among other factors, future operating results of the investments, the value of the underlying assets, and market conditions at the time of disposition, distribution, or initial public offering.

Sands Capital consists of the combination of Sands Capital Management, LLC and Sands Capital Ventures, LLC. Sands Capital operates as a distinct business organization, retains discretion over the assets between the two registered investment advisers, and has autonomy over the total investment decision making process. The private markets investment strategies discussed herein are executed by Sands Capital Ventures with certain resources, including staff, provided by Sands Capital Management.

*AUM includes the discretionary and non-discretionary assets of Sands Capital Management, LLC, and the gross assets of all funds for Sands Capital Ventures, LLC rounded to the nearest billion. Private holdings valuations for Sands Capital Ventures are updated 45 to 60 days after quarter-end.

The information presented on this website is informational only and is not to be construed, by any means, to be an offering, solicitation, advertisement or marketing material to purchase securities or interests in any investment vehicle advised by Sands Capital. Such an offer will only be made by means of a Confidential Private Offering Memorandum, which will be available solely on request, on an exclusively private basis and only to qualified financially sophisticated investors, which contains important information (including investment objectives, policies, risk factors, fees, tax implications and relevant qualifications), and only in those jurisdictions where permitted by law.

Sands Capital
1000 Wilson Boulevard, Suite 3000
Arlington, Virginia 22209 USA
1.703.562.4000

Careers | Cookies | Privacy Policy | Terms & Conditions

Sands Capital is an active, long-term investor in leading innovative businesses globally. Our approach combines analytical rigor and creative thinking to identify high-quality growth businesses that are creating the future. Through an integrated investment platform spanning venture capital, growth equity, and public equity, we provide growth capital solutions to institutions and fund sponsors in more than 40 countries.

An independent, staff-owned firm founded in 1992 and headquartered in the Washington, D.C. area with offices in London and Singapore, Sands Capital managed more than $49B* in client assets as of March 31, 2025.

Sands Capital

Portfolio Companies

Partners for long-term growth